Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Breast Neoplasms / drug therapy Carcinoma, Intraductal, Noninfiltrating / therapy Female Humans Medical Oncology

Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
06 2022
Historique:
entrez: 17 6 2022
pubmed: 18 6 2022
medline: 22 6 2022
Statut: ppublish

Résumé

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.

Identifiants

DOI: 10.6004/jnccn.2022.0030 PMID: 35714673
pubmed: 35714673
doi: 10.6004/jnccn.2022.0030
pii: jnccn2006gls
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

691-722

Auteurs

William J Gradishar (WJ)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Meena S Moran (MS)

Yale Cancer Center/Smilow Cancer Hospital.

Jame Abraham (J)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Rebecca Aft (R)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Doreen Agnese (D)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Kimberly H Allison (KH)

Stanford Cancer Institute.

Bethany Anderson (B)

University of Wisconsin Carbone Cancer Center.

Harold J Burstein (HJ)

Dana-Farber/Brigham and Women's Cancer Center.

Helen Chew (H)

UC Davis Comprehensive Cancer Center.

Chau Dang (C)

Memorial Sloan Kettering Cancer Center.

Anthony D Elias (AD)

University of Colorado Cancer Center.

Sharon H Giordano (SH)

The University of Texas MD Anderson Cancer Center.

Matthew P Goetz (MP)

Mayo Clinic Cancer Center.

Lori J Goldstein (LJ)

Fox Chase Cancer Center.

Sara A Hurvitz (SA)

UCLA Jonsson Comprehensive Cancer Center.

Steven J Isakoff (SJ)

Massachusetts General Hospital Cancer Center.

Rachel C Jankowitz (RC)

Abramson Cancer Center at the University of Pennsylvania.

Sara H Javid (SH)

Fred Hutchinson Cancer Research Center/University of Washington.

Jairam Krishnamurthy (J)

Fred & Pamela Buffet Cancer Center.

Marilyn Leitch (M)

UT Southwestern Simmons Comprehensive Cancer Center.

Janice Lyons (J)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Joanne Mortimer (J)

City of Hope National Medical Center.

Sameer A Patel (SA)

Fox Chase Cancer Center.

Lori J Pierce (LJ)

University of Michigan Rogel Cancer Center.

Laura H Rosenberger (LH)

Duke Cancer Institute.

Hope S Rugo (HS)

UCSF Helen Diller Family Comprehensive Cancer Center.

Amy Sitapati (A)

UC San Diego Moores Cancer Center.

Karen Lisa Smith (KL)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Mary Lou Smith (ML)

Research Advocacy Network.

Hatem Soliman (H)

Moffitt Cancer Center.

Erica M Stringer-Reasor (EM)

O'Neal Comprehensive Cancer Center at UAB.

Melinda L Telli (ML)

Stanford Cancer Institute.

John H Ward (JH)

Huntsman Cancer Institute at the University of Utah.

Kari B Wisinski (KB)

University of Wisconsin Carbone Cancer Center.

Jessica S Young (JS)

Roswell Park Comprehensive Cancer Center; and.

Jennifer Burns (J)

National Comprehensive Cancer Network.

Rashmi Kumar (R)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › Breast Cancer, Version 3.2022, NCCN Clinical...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Tumeurs canalaires, lobulaires et médullaires › Carcinome intracanalaire non infiltrant › Breast Cancer, Version 3.2022, NCCN Clinical...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Breast Cancer, Version 3.2022, NCCN Clinical...
questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Oncologie médicale › Breast Cancer, Version 3.2022, NCCN Clinical...